When multiple myeloma relapses
RESPOND with deeper response with Kyprolis®-based regimen (Kd)
Kd complete response
In the ENDEAVOR trial, twice as many patients achieved CR or better with Kd vs Vd.1
Adapted from Dimopoulos et al.1
Kyprolis® has a tolerable safety profile in combination with dexamethasone
*Descriptive P value.
Please read the SmPC for full comprehensive safety information
References
- Dimopoulos MA et al. Lancet Oncol 2016;17:27–38.
